Susceptibility to coeliac disease in Tunisian children and GM immunoglobulin allotypes

被引:2
作者
Bouguerra, F
Dugoujon, JM
Babron, MC
Greco, L
Khaldi, F
Debbabi, A
Bennaceur, B
Clerget-Darpoux, F
机构
[1] CHU Purpan, CNRS, ERS 1590, Unite Physiopathol Cellulaire & Mol, F-31300 Toulouse, France
[2] Hop Enfants Tunis, Tunis, Tunisia
[3] INSERM, U155, Unite Rech Epidemiol Genet, F-75016 Paris, France
[4] Univ Naples, Dept Pediat, Naples, Italy
来源
EUROPEAN JOURNAL OF IMMUNOGENETICS | 1999年 / 26卷 / 04期
关键词
D O I
10.1046/j.1365-2370.1999.00155.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Coeliac disease is a malabsorption disorder of the small intestine resulting from ingestion of gluten. The immunogenetic component is clearly demonstrated by the association of the disease with human leukocyte antigens (HLA). Among other candidate genes are the GM allotypes, which are the markers of the constant parts of heavy chains of the subclasses IgC1, IgG2 and IgG3. GM immunoglobulin allotypes have been analysed in 131 unrelated Tunisian children with coeliac disease. All patients and their parents were tested for G1M(1, 2, 3, 17), G2M(23) and G3M(5, 6, 10, 11, 13, 14, 15, 16, 21, 24, 28) by the classical haemagglutination method. Genotypes and haplotypes were deduced from phenotypes in patients and their parents. Transmission disequilibrium tests were performed in 79 informative families. The GM*3;..;5* haplotype was transmitted more often (23) than not (8) by heterozygous parents (chi(2) = 7.26; P = 0.007). This difference remained significant after correction for multiple testing. This study provides evidence for association and linkage between GM and coeliac disease. It suggests that GM or genes close to GM play a role in the development of the disease.
引用
收藏
页码:293 / 297
页数:5
相关论文
共 34 条
[1]   Systematic search of susceptibility loci with methods using gametic disequilibrium [J].
Bickeboller, H ;
MargaritteJeannin, P ;
Babron, MC ;
ClergetDarpoux, F .
GENETIC EPIDEMIOLOGY, 1995, 12 (06) :577-582
[2]  
Bouguerra F, 1997, GENET EPIDEMIOL, V14, P413, DOI 10.1002/(SICI)1098-2272(1997)14:4<413::AID-GEPI6>3.0.CO
[3]  
2-3
[4]   GM MARKERS IN CELIAC-DISEASE [J].
CARBONARA, AO ;
DEMARCHI, M ;
VANLOGHEM, E ;
ANSALDI, N .
HUMAN IMMUNOLOGY, 1983, 6 (02) :91-95
[5]  
CARUSO C, 1991, EXP CLIN IMMUNOGENET, V8, P1
[6]   IGA ANTI-ENDOMYSIUM ANTIBODY - A NEW IMMUNOLOGICAL MARKER OF DERMATITIS-HERPETIFORMIS AND CELIAC-DISEASE [J].
CHORZELSKI, TP ;
BEUTNER, EH ;
SULEJ, J ;
TCHORZEWSKA, H ;
JABLONSKA, S ;
KUMAR, V ;
KAPUSCINSKA, A .
BRITISH JOURNAL OF DERMATOLOGY, 1984, 111 (04) :395-402
[7]  
CICLITIRA PJ, 1984, GUT, V25, pA574
[8]  
CLERGETDARPOUX F, 1994, CR ACAD SCI III-VIE, V317, P931
[9]  
CLERGETDARPOUX F, 1997, GENETIC DIVERSITY HL, V2, P718
[10]   CHROMOSOMAL LOCATION OF THE GENES FOR HUMAN-IMMUNOGLOBULIN HEAVY-CHAINS [J].
CROCE, CM ;
SHANDER, M ;
MARTINIS, J ;
CICUREL, L ;
DANCONA, GG ;
DOLBY, TW ;
KOPROWSKI, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (07) :3416-3419